Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
08/2006
08/01/2006US7084241 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases
08/01/2006US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease
08/01/2006US7084134 Such as (6R,20aS)-16-chloro-6-cyclohexyl-2,3,6,7,9,10,18,19-octahydro-1H- pyrrolo-(1,2-j)(1,4,7,10,13)-benzoxatetraazacyclohexadecine -5,8,11,20(12H,20aH)-tetrone
08/01/2006US7084120 Prodrugs of DP IV-inhibitors
08/01/2006US7084108 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
07/2006
07/27/2006WO2006047900A3 Novel topical application agents against mimic and age-related wrinkles
07/27/2006WO2005100381A3 Processes for preparing eptifibatide and pertinent intermediate compounds
07/27/2006WO2005082005A3 Positive modulator of bone morphogenic protein-2
07/27/2006WO2005002516A9 Leukocyte internalized peptide-drug conjugates
07/27/2006US20060167229 Biologically active peptide conjugates
07/27/2006US20060167223 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use
07/27/2006US20060167222 Sh2 domain binding inhibitors
07/27/2006US20060166961 Cell adhesion inhibitors
07/27/2006US20060166897 Novel indazole peptidomimetics as thrombin receptor antagonists
07/27/2006US20060166896 Novel indazole peptidomimetics as thrombin receptor antagonists
07/27/2006US20060166895 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease
07/27/2006US20060166894 Ace-inhibitors having antioxidant and no-donor activity
07/27/2006US20060166893 Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments
07/27/2006US20060166891 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
07/27/2006US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes
07/27/2006US20060166866 Cell adhesion inhibitors
07/27/2006US20060166863 Inhibitor and stimulator of stem cell proliferation and uses thereof
07/27/2006US20060166858 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals
07/27/2006US20060166296 Standard compound for immunoassay for dioxin and method of immunoassay for dioxin
07/27/2006US20060165654 Peptides and recombinant proteins mimicking interferons
07/26/2006EP1682570A1 A binding motif and methods of regulating cell function
07/26/2006EP1682546A1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates
07/26/2006EP1682524A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors
07/26/2006EP1682074A2 Compositions and methods for healthy pregnancy
07/26/2006EP1449917B1 Process for producing l-amino acid using escherichia
07/26/2006CN1809590A Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
07/26/2006CN1809586A Biologically active peptide comprising tyrosyl-seryl-valine (YSV)
07/26/2006CN1809585A Process for the production of melagatran
07/26/2006CN1809345A Enalapril-nitroxyderivatives derivatives and related compounds as ACE inhibitors for the treatment of cardiovascular diseases
07/26/2006CN1807447A Glutathion purification and separation method
07/25/2006US7081495 Cationic compounds and their use as macro molecular carriers
07/25/2006US7081447 Organic compounds with biological activity as thrombin inhibitors and use thereof
07/25/2006US7080906 Translating bifocal wear modality
07/25/2006CA2156935C Methods of detecting collagen degradation in vivo
07/25/2006CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof
07/20/2006WO2006037775A8 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments
07/20/2006WO2005016955A3 Nogo receptor antagonists
07/20/2006US20060160886 Chemical compounds
07/20/2006US20060160885 Chemical compounds
07/20/2006US20060160749 Tripeptide and tetrapeptide thioethers
07/20/2006US20060160747 Statine derivatives for the treatment of Alzheimer's disease II
07/20/2006US20060160731 Peptide nucleic acids
07/20/2006US20060160726 Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors
07/20/2006US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy
07/19/2006EP1680443A2 Stabilized alpha helical peptides and uses thereof
07/19/2006EP1483284B1 Selective dipeptide inhibitors of kallikrein
07/19/2006CN1805972A Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
07/19/2006CN1805932A Process and intermediates for the preparation of (1r,2s,5s)-3-azabicyclo[3,1,0]hexane-2-carboxamide, n-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[1,1-dimethylethyl]amino]carbonylamino
07/19/2006CN1805752A Water-soluble shps as novel alkylating agents
07/19/2006CN1804628A Peptide for distinguishing prion
07/19/2006CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use
07/19/2006CN1264856C Inhibitor and stimulator of stem cell proliferation and uses thereof
07/18/2006US7078572 Preparing an aldehyde intermediates for anticancer drugs, by decyclization of a substituted oxiranes or reducing a nitrile with a reducing agent; free of hazard azide intermediate, no need of purification by column chromatography
07/18/2006US7078165 Gene expression of cells; genetic engineering using tripeptides; antiinflammatory agents; apoptosis;medical diagnosis
07/18/2006US7078042 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
07/18/2006CA2224528C Stilbene compositions in the adamantyl group, compositions containing them and uses
07/13/2006WO2006074409A1 Tripeptide and tetrapeptide sulfones
07/13/2006WO2006074249A1 Tripeptide and tetrapeptide thioethers
07/13/2006WO2006042478A8 Small-molecule inhibitors of coronaviral main protease, their preparation and use
07/13/2006WO2004078908A3 Alpha-keto carbonyl calpain inhibitors
07/13/2006US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
07/13/2006US20060154871 Peptides
07/13/2006CA2587310A1 Tripeptide and tetrapeptide sulfones
07/13/2006CA2587284A1 Tripeptide and tetrapeptide thioethers
07/12/2006EP1679303A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative
07/12/2006EP1678200A2 A method of modulating cell survival, differentiation and/or synaptic plasticity
07/12/2006EP1678196A1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
07/12/2006EP1338604B1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres
07/12/2006EP0869808B1 Use of glu-trp dipeptides for the manufacture of a medicament for the treatment of different conditions involving neovascularization
07/12/2006CN1802384A Method for synthesis of perindopril and its pharmaceutically acceptable salts
07/12/2006CN1800213A Peptides
07/12/2006CN1263770C Novel peptides and medicinal uses thereof
07/11/2006US7074786 Histogranin-like peptides, processes for their preparation and uses thereof
07/11/2006US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents
07/11/2006US7074765 Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
07/11/2006US7074620 Controlling protein levels in eucaryotic organisms
07/11/2006US7074615 Peptides for enhanced cell attachment and cell growth
07/11/2006US7074580 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight
07/11/2006CA2227984C Aza-anthracyclinone derivatives
07/06/2006WO2006070780A1 Par-2 agonist
07/06/2006WO2006070276A1 Process for preparing perindopril erbumine
07/06/2006WO2005010022A3 Agonist polypeptide of receptor for zot and zonulin
07/06/2006US20060149082 Novel method for synthesising derivatives of (2s,3as,7as)-1-[(s)-alanyl]-octahydro,-1h-indole-2-carboxylic acid and the use thereof for perindopril synthesis
07/06/2006US20060149032 Recombinant hepatitis B surface antigen
07/06/2006US20060148884 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
07/06/2006US20060148734 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds
07/06/2006US20060148718 complex of cytotoxic agent to polypeptides; amino acid sequence proteolytic splitting protate specific antigen; therapy for protate cancer and benign prostate hyperplasia
07/06/2006US20060148710 Oligopeptides, composition and use thereof as elicitors of the natural defences of plants
07/06/2006US20060148678 Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products
07/06/2006DE112004001603T5 TGF-β-Genexpressionsinhibitor TGF-β gene expression inhibitor
07/06/2006DE102004063339A1 Sonde zum Nachweis von Nukleinsäuren Probe for detecting nucleic acids
07/05/2006EP1676855A2 Prenyl transferase inhibitors
07/05/2006EP1676839A2 Novel beta crystalline form of perindopril tert-butylamine salt, its preparation method and pharmaceutical compositions containing same
07/05/2006EP1497316B1 Growth hormone secretagogues
07/05/2006CN1262651C Method for giving resistance to weed control compounds to plants